Jump to main content
Jump to site search

Issue 8, 2015
Previous Article Next Article

Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods

Author affiliations

Abstract

TRAF-2 and NCK-interacting kinase (TNIK) is a serine–threonine kinase with a proposed role in Wnt/β-catenin and JNK pathways. Due to its implication in Wnt-mediated colorectal carcinogenesis, selective TNIK inhibition has emerged as an attractive anti-cancer therapeutic strategy. So far, only a few TNIK inhibitors have been described and none of them reached advanced preclinical development. In this study, a virtual screening approach was applied for the investigation of novel TNIK inhibitors. The best performing ShaEP methodology for similarity searching was applied for screening of a commercially available small-molecule database. Among several discovered TNIK kinase inhibitors, a compound containing the furan-2-carboxamide scaffold was found to be the most active, with IC50 = 0.85 μM. An advanced substructure search led to the discovery of a more potent and selective compound with IC50 = 258 nM. The most active compounds were tested in vitro for their effect on the Wnt/β-catenin pathway and proliferation of Wnt-active colorectal cancer cells. The compounds identified in this study represent attractive starting points for the development of more potent and selective small-molecule TNIK inhibitors for both therapeutic application and research into TNIK's biological role.

Graphical abstract: Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 03 Mar 2015, accepted on 24 Jun 2015 and first published on 24 Jun 2015


Article type: Concise Article
DOI: 10.1039/C5MD00090D
Citation: Med. Chem. Commun., 2015,6, 1564-1572
  •   Request permissions

    Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods

    A. Bujak, F. Stefaniak, D. Zdzalik, P. Grygielewicz, B. Dymek, M. Zagozda, P. Gunerka, M. Lamparska-Przybysz, K. Dubiel, M. Wieczorek and K. Dzwonek, Med. Chem. Commun., 2015, 6, 1564
    DOI: 10.1039/C5MD00090D

Search articles by author